Safety Study Comparing Phenylephrine HCL Extended Release Tablets 30 mg and Placebo (Study CL2007-07)(P07529)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Blood PressureHuman Experimentation

Interventions

DRUG

Phenylephrine Hydrochloride (HCl) Extended-Release tablets 30 mg

Phenylephrine HCl Extended-Release tablets 30 mg taken twice daily (12 hours apart) for 7 days.

DRUG

Placebo

Placebo taken twice daily (12 hours apart) for 7 days.